Unity Biotechnology Inc


UBX

Price

1.48


Change

-0.01


High

NA


Low

1.46


Avg Volume

58,007


PE Ratio

NA


52 Week High

3.82


52 Week Low

1.46



Profile

Unity Biotechnology is a startup biotechnology company that develops drugs which target senescent cells. The company's products in development include UBX0101, targeting knee osteoarthritis , and UBX1967, a preclinical product targeting ophthalmologic diseases. Both are senolytic medicines.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.